The Influence of Miniaturization on Orthopedic Innovation

Miniaturization plays an increasingly important role in orthopedic device design, driven by the demand for less-invasive procedures, improved patient outcomes, and more sophisticated implant systems. Today’s orthopedic devices are becoming smaller and smarter, enabling earlier intervention, improved patient comfort, reduced recovery times, and a greater ability to deliver care outside traditional hospital settings.

As a result, miniaturization has a big impact on orthopedic innovation as the industry moves toward minimally invasive procedures. “This shift puts more pressure on manufacturers to achieve smaller features and tighter tolerances,” said Craig Herron, engineering manager for Wilmington, Mass.-based Elevaris Medical Devices, a medical equipment manufacturer that specializes in precision micro components and complex tubular components. “The smaller and more precise the devices become, the less risk to the patient and the faster the recovery time.”

“Achieving this level of performance requires far more than simply shrinking a design,” added John Clark, CEO for MTD Micro Molding, a U.S.-based contract manufacturer (CM) that specializes in advanced micro injection molding for the medical device industry. “It requires expertise in materials science, precision tooling, micro injection molding, automation, and scientific process control. Manufacturers must consistently produce components measured in fractions of a millimeter while maintaining the reliability and repeatability expected of medical devices.” 

For most orthopedic manufacturers, miniaturization has moved from a “nice-to-have” feature to being the key driver behind modern surgical innovation. “In robotic and minimally invasive procedures, every millimeter of shaft diameter matters,” said Kai Wissner, CEO for Germany-based Hipp & Son (HS), a CM specializing in miniaturized instruments for robotic and minimally invasive surgery. “Smaller instruments mean smaller incisions, less tissue trauma, and faster recovery. What has changed in recent years is the degree of functional integration. It is no longer just about making a single part smaller—it is about packaging complete mechanical systems, such as multi-stage gear trains, articulation joints, and force transmission elements, into a distal tip of just a few millimeters in diameter.”

Miniaturization also allows designers and engineers to create orthopedic products that could not previously be made, such as “new procedures for tendon and small bone repair, resulting in better outcomes for these types of surgeries,” said Jeff Haag, vice president of technical solutions for Big Lake, Minn.-based Precera Medical, a contract development and manufacturing organization (CDMO) that develops and manufactures precision components and assemblies for the medical device industry.

As orthopedic devices become smaller and more complex, micro injection molding has emerged as a key manufacturing technology for producing high-precision polymer components that cannot be economically or consistently manufactured using conventional molding methods.

“Today, micro injection molding is used to manufacture miniature orthopedic components such as implant delivery system parts, spinal instrumentation components, arthroscopy device features, suture anchor components, locking mechanisms, and precision inserts for minimally invasive surgical instruments,” said Scott Herbert, founder of the recently acquired Rapidwerks and director of Micro Molding at Cordica Medical, a Knoxville, Tenn.-based CDMO of non-discretionary, consumable medical devices. “These parts often weigh less than a gram and incorporate intricate geometries, micro-scale features, and extremely tight dimensional tolerances.”

Latest Trends

One of the most significant miniaturization trends is packing more functionality into increasingly smaller devices. Orthopedic devices can now have more sensing capabilities, connectivity, and advanced materials, while still maintaining extremely compact form factors. “We are also seeing greater demand for multi-material components, insert molding, overmolding, and bioabsorbable polymers that enable entirely new treatment options,” said Clark.

Orthopedic manufacturers are also placing greater value on partners that can deliver more value by simplifying their supply chains. Rather than managing multiple suppliers, “companies increasingly want a vertically integrated partner capable of supporting design refinement, tooling, molding, metrology, validation, assembly, and inspection under one quality system,” said Lindsay Mann, director of commercial strategy for MTD Micro Molding. “This approach not only improves communication but also shortens development timelines and reduces project risk.”

These original equipment manufacturer (OEM) expectations shift the responsibility for tolerance stacks, assembly processes, functional testing, and other requirements to the CM. For example, new robotic surgery platforms target smaller wristed instruments with more degrees of freedom at the tip. “The wrist of a robotic instrument is essentially a miniature gearbox, and the demand for gears in the module range of 0.1 mm and below has grown dramatically,” said Wissner.

There is also more demand for lubrication-free mechanisms. Greases and oils in a surgical instrument are a liability because they complicate cleaning validation and can migrate within the device. “This is why HS developed its LUBFREE technology—engineered material pairings and surface treatments that let miniature gears and bearings run dry under high-contact stresses, with proven fatigue life,” added Wissner.

Inspired by the aerospace industry, many orthopedic manufacturers are redesigning assemblies to incorporate high-performance polymers in applications that have historically relied on machined metal parts. “Materials such as polyetheretherketone [PEEK], polyphenylsulfone [PPSU], and bioabsorbable polymers enable designers to reduce weight, integrate multiple functions into one component, and simplify assembly while maintaining performance,” said Herbert.

Design requests from OEMs include micro holes, thin ribs, fine threads, small locking geometries, and features measured in only a few thousandths of an inch. These designs strongly favor micro injection molding because the process excels at producing small, intricate polymer components with exceptional repeatability. “As orthopedic devices continue to evolve toward minimally invasive, lightweight, and highly integrated designs, micro molding will increasingly be an enabling technology, rather than just a manufacturing option,” said Herbert.

From product launches to M&A and manufacturing trends, the ODT Now delivers the orthopedic device news you need weekly. Subscribe here!

What OEMs Want

Orthopedic companies want components with thinner walls, tighter tolerances, increasingly complex geometries, and greater functional integration—all without compromising strength, reliability, or production scalability.

“These demands challenge manufacturers to truly understand machine and process capability limits and inform designers on what is possible,” said Herron.

For example, integrating multiple functions into a single molded part provides several advantages. Instead of assembling several miniature components, engineers can design a single molded part that includes locking features, snap fits, living hinges, fluid pathways, and instrument alignment features. This reduces assembly costs and improves consistency and reliability.

CMs and CDMOs that can quickly scale from prototype to production have a competitive advantage in the industry. Many orthopedic programs begin with relatively low volumes but may scale rapidly after regulatory approval. “OEMs want manufacturing partners that can support prototype and pilot production, process validation, automated, high-volume manufacturing, and consistent quality throughout the product lifecycle,” said Herbert.

With these expanding complexities, orthopedic OEMs increasingly ask for early design for manufacturability (DFM) involvement. “The best miniaturized designs are created when the manufacturer sits at the table during development, because at these scales, the design and the manufacturing process cannot be separated,” said Wissner. “And of course, OEMs expect a complete validation package—installation qualification, operational qualification, and performance qualification (IQ/OQ/PQ), measurement system analyses, and cleaning validation support.”

Above all else, OEMs expect devices to function consistently and reliably with minimal variation. “At the micro scale, even seemingly insignificant dimensional variation can have a major impact on device performance,” said Maggie Beauregard, director of quality for MTD Micro Molding. “Early collaboration between the manufacturing partner and OEM design team is critical to ensure the device functions as intended while remaining manufacturable and measurable.”

Integrated Manufacturing Practices

The convergence of advanced polymers, micro injection molding technology, precision tooling, high-resolution metrology, and automation continues to spur creative thinking in design. Improvements in simulation software, mold manufacturing, and non-contact inspection “allow us to produce increasingly complex geometries with greater consistency than ever before,” said Clark.

Technology advances in materials, manufacturing techniques, automation, and digital engineering allow OEMs to make devices smaller, more functional, and easier to manufacture. Improvements in micro machining, electrical discharge machining (EDM), laser machining, and ultra-precision grinding allow mold makers to produce tooling with extremely fine features and exceptional surface finishes. The combination of Swiss-type micro turning, five-axis micro milling, and wire and sink EDM now enables features in the range of a few thousandths of an inch with excellent repeatability. “Micro gear cutting has advanced to the point where we produce gears with modules around 0.1 mm and below in medical-grade stainless steels in series quality,” said Wissner.

In some ways, metrology is more important than the manufacturing method. Without capable measurement, miniaturization is guesswork. As parts become smaller and more complex, traditional inspection methods are increasingly insufficient. Vision inspection, optical measurement, computed tomography (CT) scanning, automated inspection, and advanced metrology may be required. The measurement system itself must be validated so the orthopedic OEM and CM know whether they are seeing actual process variation or measurement noise.

Smaller-format equipment for processing of smaller parts allows for more optimized processing. “The smaller a tool used in the machining process, the higher the RPM that is needed to optimize material removal and tool life,” said Haag. “New machine tools are designed with these needs in mind to make the processing of small parts more efficient.”  

Advanced micro injection molding technology produces increasingly complex components with shot sizes measured in milligrams and features measured in microns. Improvements in machine control, tooling, and process monitoring enable manufacturers to consistently mold:

• Thin-wall components 
• Micro-scale holes and channels 
• Precision snap fits and locking features 
• Highly intricate geometries with excellent repeatability 

These capabilities are especially valuable for minimally invasive surgical instruments and implant delivery systems.

Manufacturers also use artificial intelligence (AI) and machine learning to monitor molding processes in real time. “These systems can detect subtle process variations, predict quality issues before defects occur, and optimize machine settings automatically,” said Herbert. “Digital process monitoring is especially valuable when producing components with micron-level tolerances.”

Sophisticated simulation tools—including mold flow analysis, finite element analysis (FEA), and tolerance stack-up modeling—allow engineers to optimize miniature components before tooling is built. This reduces development time and helps ensure parts meet performance and manufacturability requirements. Increased adoption of digital twins and simulation-driven design continues to shorten development cycles and improve manufacturability.

How Small Is Small?

As technology advances, so do the limits of miniaturization. “Today we are developing tooling for components measuring approximately 0.011 inches in diameter and weighing just 0.000012 grams, while simultaneously producing parts with uniform wall sections as thin as 0.003–0.004 inches,” said Randy Guertin, lead tool designer and tooling supervisor for MTD Micro Molding.

The limiting factor on “how small” is rarely size alone. Materials, tooling, assembly, inspection, sterilization, and the ability to manufacture consistently at production volumes all influence what is practical. “Today the question is not simply can we make it,” said Clark, “but can we make it reliably, shot to shot and lot to lot?”

HS can produce functional features in the range of a few hundredths of a millimeter, and gears with modules around 0.05 mm are feasible. However, Wissner agreed the practical limit is rarely defined by the machine tool; instead, real limits on size include: 

• Measurement—You can only produce what you can reliably measure.
• Assembly—Sub-millimeter parts need defined handling and joining processes.
• Economics—Yield at the edge of feasibility determines whether a design is viable in series production.

There is also a materials limit: below a certain feature size, the grain structure of the material itself becomes relevant to strength and function. “In our experience,” Wissner added, “the sweet spot today for high-load, high-life mechanisms—such as robotic instrument wrists—is in gear modules from roughly 0.08 mm to 0.2 mm. Below that, everything is possible in principle, but each step-down must be justified by the application.”

Herbert indicated that today’s micro injection molding technology is capable of producing components that:

• Weigh just a few milligrams 
• Feature wall thicknesses below 0.1 mm (100 microns) in some applications 
• Incorporate features measured in tens of microns 
• Hold dimensional tolerances on the order of ±10–25 microns, depending on part geometry, material, and process capability 

These capabilities make micro molding well-suited for miniature components used in implant delivery systems, arthroscopic instruments, spinal devices, and surgical instrumentation.

Challenges to Miniaturization

One of the biggest challenges to overcome is that medical designers often think miniaturization is simply about making a device or component smaller. 

“Miniaturization changes the entire engineering, manufacturing, inspection, validation, and usability equation,” said Rob Morin, vice president of sales and marketing for Scottsdale, Ariz.-based PDC, a contract manufacturer specializing in micro injection molding for the medical device industry. “A smaller device does not automatically create a better device. It only creates value if it can still perform safely, be manufactured repeatably, be inspected reliably, be validated appropriately, and be used effectively by the physician or patient.”

The next challenge is balancing size reduction with functional performance. In many applications, the device becomes smaller while still maintaining strength, flexibility, torque response, sealing, deployment accuracy, durability, and biocompatibility. That is especially true in cardiovascular, neurovascular, electrophysiology, structural heart, robotic surgery, drug delivery, diabetes care, and implantable devices. “For example,” said Morin, “a catheter-based device may need a smaller profile to navigate difficult anatomy, but it still must transmit force, resist kinking, maintain lumen integrity, and deliver therapy accurately. Reducing the profile can create tradeoffs in stiffness, strength, flow, and control.”

Material selection is not always a straightforward process. As devices become smaller, the material has to do more work in less space. Orthopedic OEMs may need materials that are thin-walled, strong, flexible, lubricious, transparent, chemically resistant, sterilization-compatible, or suitable for long-term patient contact. In some applications, the material may also need to bond to another material, survive assembly loads, or maintain dimensional stability after sterilization.

Tooling and manufacturing process development should be discussed during DFM. Miniaturized components often have thin walls, small features, tight shutoffs, delicate geometry, and challenging tolerance requirements. In precision molding, the tool must support consistent filling, venting, cooling, ejection, and long-term maintenance. “A feature that is technically moldable one time may not be practical for repeatable production if it creates tool wear, flash risk, ejection damage, or excessive scrap,” said Morin. “That is why early DFM review is so important. The goal is to identify which features are truly critical to function and which features can be modified to improve manufacturability, without compromising clinical performance.”

Tolerancing also becomes much more difficult as components get smaller. A few thousandths of an inch may not matter on a larger component, but on a miniature device, it can affect fit, sealing, force transmission, fluid flow, actuation, or deployment. Orthopedic OEMs sometimes apply extremely tight tolerances across the entire drawing because the part is small. “This, however, can drive unnecessary cost and risk,” said Morin. “A better approach is to identify critical-to-function dimensions and build the manufacturing and inspection strategy around those features.”

Moving Ahead

Many miniaturized orthopedic components include features measured in tens or hundreds of microns. Successfully molding or machining these features requires ultra-precision tooling, tight process control, consistent material flow, and specialized molding equipment. “Even slight variations in temperature, pressure, or material viscosity can lead to incomplete filling or dimensional inaccuracies,” said Herbert.

Measurement of miniature parts continues to be a major challenge. “CT scanning remains a critical instrument in the measurement of very small parts, but these scanners are still slow relative to other measurement devices, making them a challenge to implement in a medium or high-volume production application,” said Haag. “Developing metrology techniques for miniature parts and correlation with customers is critical.”

Beauregard agreed.

“As designs continue to evolve, manufacturers must continually invest in new inspection technologies capable of verifying increasingly smaller features with confidence,” she added.

Upcoming advances in several areas are expected to push the practical limits of miniaturization. These include:

• Higher-resolution micro tooling and laser machining 
• Better simulation tools for predicting polymer flow and shrinkage 
• AI-assisted process control for tighter manufacturing consistency 
• Improved metrology for verifying micro scale features 
• New high-performance polymers with greater strength and flow characteristics 

“These advances will enable smaller and more complex orthopedic components, while improving manufacturing yields,” said Herbert.

In reality, the greatest successes occur when miniaturization is approached as a collaborative engineering effort. “The best outcomes result from early partnership among product designers, materials experts, tooling engineers, manufacturing specialists, and quality teams,” said Herbert. “When these disciplines work together from the outset, orthopedic companies are often able to achieve smaller, more capable, and more manufacturable devices than they initially believed possible.”

What excites Mann the most is that miniaturization is enabling entirely new therapies rather than simply making existing devices smaller. “Every year, we see concepts that once may have been dismissed as impossible become manufacturable, not only because technology continues to advance, but because the expertise to push those boundaries has advanced with it,” she said. “That expertise gives us the confidence to challenge perceived limitations and develop solutions that move innovative ideas into production.”

Mark Crawford is a full-time freelance business and marketing/communications writer based in Corrales, N.M. His clients range from startups to global manufacturing leaders. He has written for MPO and ODT magazines for more than 15 years and is the author of five books.